The global e-prescribing (e-Rx) market is anticipated to amplify with a significant CAGR over the forecast period of 2022-2030.
Since prescription mistakes account for more than 70% of drug errors reported by hospitals and general practise settings, they are the main source of worry for healthcare workers worldwide. Although these mistakes seldom result in death, they can seriously harm a patient's health. Prescription errors not only put patients' health at risk but also frequently result in lawsuits for medical and legal misconduct against doctors and other medical professionals.
In the United Kingdom, these prescribing errors and faults are recorded in 9% to 15% of drug orders for hospital inpatients, according to the General Medical Council (GMC) report, . In most cases, these errors can be reduced by over 85% by using e-prescribing systems. By implementing warnings and alert systems at the moment of prescription, e-prescribing technology can help patients and doctors get the whole picture of their medical histories while also reducing the likelihood of errors.
An Increase in e-Prescribing Use is Caused by Covid-19
Health care providers were forced to alter their service delivery strategies as a result of Covid-19, which had a negative influence on health services across the globe. After the Covid-19 outbreak, e-Prescribing became a crucial tool for establishing a secure environment and reducing in-person consultations and paper prescription handling.
Favorable Regulatory Changes in Different Countries Give the e-Prescribing Market a Boost
The Covid-19 pandemic has made it necessary to alter the e-prescription regulations so that individuals may quickly and effectively access a variety of healthcare services.
The federal government and a number of states, including California, Indiana, Maryland, Michigan, Nebraska, New Hampshire, Utah, and Washington, have made electronic prescribing of controlled substances in the US mandatory in an effort to reduce the rise in drug-related fatalities in the country. Clinical prescribers must electronically record controlled drugs according to the regulation.
State governments had until January 1st, 2021, to comply with federal EPCS regulations. However, the Centers for Medicare and Medicaid Services (CMS) have delayed the implementation of EPCS-certified E-Prescribing software for Medicare Part D until January 1, 2023 due to COVID-19 issues. CMS continues to promote adoption in order to help practises avoid fines for non-compliance.
Global E-Prescribing (e-Rx) Market- Key trends Emergence of the COVID-19 pandemic is aiding industry expansion The onset of the COVID-19 pandemic brought about new transformations in the healthcare sector. Various governments pushed the adoption of EHR solutions as a measure to reduce the escalating healthcare costs. Moreover, the use of e-prescriptions also reduced the physical contact between the practitioner and pharmacists, thereby keeping the coronavirus infection rates at bay. This in turn is adding traction to the growth of this market vertical.
Get Free Sample Reports: https://wemarketresearch.com/sample-request/e-prescribing-(e-rx)-market/350/
Global E-Prescribing (e-Rx) Market- Segmental assessment By Production • Solutions • Services By Delivery Mode • Web/Cloud Based • On Premise The web/cloud based segment is likely to generate a high volume share over the analysis timeline owing to their ease of deployment and cost effectiveness. By End Use • Hospitals • Office based Physicians • Pharmacy By Usage Methods • Handheld • Computer based devices The handheld segment is reckoned to grow considerably over the forecast period attributing to the ease of use and affordability of handheld devices. By Substances • Controlled • Non-Controlled The controlled segment is anticipated to garner significant returns by 2030 due to the growing incidences of drug abuse across the globe. By Specialties • Oncology • Sports Medicine • Neurology • Cardiology • Others The oncology segment is poised to amass notable gains over the stipulated timeline owing to the growing prevalence of cancer worldwide.
Competitive hierarchy
The prominent players characterizing the competitive terrain of this business vertical are Epic Systems Corporation (US), Cerner Corporation (US), Allscripts (US), NextGen Healthcare (US), athenahealth, Inc. (US), RelayHealth, LLC (US), Henry Schein, Inc. (US), GE Healthcare (US), Computer Programs and Systems, Inc. (US), DrFirst, Inc. (US), Surescripts-RxHub, LLC (US), and Medical Information Technology, Inc.
Notably, in June 2019, Allscripts announced the acquisition of ZappRx to enhance its offerings in the field of EHR solutions.
Access the Complete Report at: https://wemarketresearch.com/reports/e-prescribing-(e-rx)-market/350/
Major questions answered in this report
What is the growth rate projection for Global E-Prescribing (e-Rx) Market over 2022-2030?
What are the expansion determinants for Global E-Prescribing (e-Rx) Market?
What are the major segments covered in the Global E-Prescribing (e-Rx) Market report?
What are the primary regions present in the Global E-Prescribing (e-Rx) Market?
Which is the fastest growing region in the Global E-Prescribing (e-Rx) Market?
About We Market Research:
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact Us:
We Market Research
Phone: +1(650)-666-4592
Email: sales@wemarketresearch.com
